VI
GILD icon

Vestcor Inc’s Gilead Sciences GILD Stock Holding History

Vestcor Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5M Sell
169,809
-13,674
-7% -$1.8M 0.53% 35
2026
Q1 		$25.6M Sell
183,483
-39,732
-18% -$5.56M 0.7% 22
2025
Q4 		$27.4M Sell
223,215
-888
-0.4% -$108K 0.78% 16
2025
Q3 		$24.9M Sell
224,103
-3,592
-2% -$408K 0.74% 19
2025
Q2 		$25.2M Buy
227,695
+23,514
+12% +$2.5M 0.76% 18
2025
Q1 		$22.9M Sell
204,181
-14,070
-6% -$1.45M 0.77% 24
2024
Q4 		$20.2M Buy
218,251
+2,894
+1% +$261K 0.67% 30
2024
Q3 		$18.1M Sell
215,357
-40,936
-16% -$3.12M 0.57% 33
2024
Q2 		$17.6M Sell
256,293
-41,172
-14% -$2.75M 0.59% 33
2024
Q1 		$21.8M Sell
297,465
-8,844
-3% -$680K 0.75% 26
2023
Q4 		$24.8M Sell
306,309
-284
-0.1% -$22.1K 0.84% 23
2023
Q3 		$23M Buy
306,593
+6,842
+2% +$526K 0.84% 22
2023
Q2 		$23.1M Sell
299,751
-4,568
-2% -$364K 0.84% 19
2023
Q1 		$25.2M Buy
304,319
+73,405
+32% +$6.08M 0.92% 15
2022
Q4 		$19.8M Buy
230,914
+6,240
+3% +$494K 0.73% 26
2022
Q3 		$13.9M Buy
224,674
+2,167
+1% +$137K 0.52% 40
2022
Q2 		$13.8M Buy
222,507
+5,166
+2% +$320K 0.51% 40
2022
Q1 		$12.9M Sell
217,341
-1,304
-0.6% -$83.4K 0.44% 50
2021
Q4 		$15.9M Sell
218,645
-10,955
-5% -$755K 0.56% 42
2021
Q3 		$16M Sell
229,600
-6,699
-3% -$471K 0.58% 40
2021
Q2 		$16.3M Sell
236,299
-4,935
-2% -$330K 0.55% 40
2021
Q1 		$15.6M Buy
241,234
+25,701
+12% +$1.66M 0.58% 25
2020
Q4 		$12.6M Buy
215,533
+21,085
+11% +$1.27M 0.52% 39
2020
Q3 		$12.3M Sell
194,448
-774
-0.4% -$53.7K 0.57% 36
2020
Q2 		$15M Buy
195,222
+168,134
+621% +$12.9M 0.78% 19
2020
Q1 		$2.02M Buy
27,088
+5,150
+23% +$356K 0.11% 208
2019
Q4 		$1.43M Buy
+21,938
New +$1.43M 0.07% 310

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vestcor Inc's GILD Position: Q2 2026 in Review

Vestcor Inc reduced its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, selling an estimated $1.8M and leaving 169,809 shares worth $21.5M. The position accounts for 0.53% of the portfolio, ranked #35.

Vestcor Inc first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $27.4M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vestcor Inc held 169,809 shares of Gilead Sciences worth $21.5M as of Q2 2026.
  • Vestcor Inc sold 13,674 Gilead Sciences shares in Q2 2026, an estimated $1.8M.
  • Gilead Sciences made up 0.53% of Vestcor Inc's portfolio in Q2 2026, its #35 holding.
  • Vestcor Inc first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's Gilead Sciences position peaked at $27.4M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.